6C4B.5

ICD-11 MMS 2026-01

Volatile inhalant-induced delirium

Description

Volatile inhalant-induced delirium is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or withdrawal or during the use of volatile inhalants. The amount and duration of volatile inhalant use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders.

Index terms

  • Volatile inhalant-induced delirium
  • Mental and behavioural disorders due to use of volatile inhalants withdrawal state with delirium

Exclusions from above levels

  • 6D72.13 – Amnestic disorder due to use of volatile inhalants
  • QE62 – Uncomplicated bereavement
  • QE84 – Acute stress reaction

Sibling codes

  • 6C4B.0 – Episode of harmful use of volatile inhalants
  • 6C4B.1 – Harmful pattern of use of volatile inhalants
  • 6C4B.2 – Volatile inhalant dependence
  • 6C4B.3 – Volatile inhalant intoxication
  • 6C4B.4 – Volatile inhalant withdrawal
  • 6C4B.6 – Volatile inhalant-induced psychotic disorder
  • 6C4B.7 – Certain specified volatile inhalants-induced mental or behavioural disorders
  • 6C4B.Y – Other specified disorders due to use of volatile inhalants
  • 6C4B.Z – Disorders due to use of volatile inhalants, unspecified

Foundation entity

Volatile inhalant-induced delirium – http://id.who.int/icd/entity/1030552808

Allowed postcoordination axes

Part of: 6C4B: Disorders due to use of volatile inhalants › 06: Mental, behavioural or neurodevelopmental disorders